{
    "2018-07-16": [
        [
            {
                "time": "",
                "original_text": "长生生物爆雷，疫苗股投资逻辑受考验",
                "features": {
                    "keywords": [
                        "长生生物",
                        "爆雷",
                        "疫苗股",
                        "投资逻辑"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "300122智飞生物:五价轮状协议确定,市场替代值得期待",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "五价轮状",
                        "协议确定",
                        "市场替代"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}